Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
2.08
Nov 20 • 3:59 PM ET Dollar change-0.26 Percentage change(-11.11%)
Aftermarket Close
2.08
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
32.22M
Enterprise Value
26.31M
Income
-3.58M
Sales
1.91M
Book/sh
9.20
Cash/sh
0.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9
IPO
Jan 25, 2018
P/E
-
Forward P/E
1.34
PEG
-
P/S
16.87
P/B
0.23
P/C
4.87
P/FCF
-
EV/EBITDA
-
EV/Sales
13.77
Quick Ratio
3.76
Current Ratio
3.76
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-2.26
EPS next Y
1.55
EPS next Q
0.47
EPS this Y
161.49%
EPS next Y
-73.18%
EPS next 5Y
-
EPS past 3/5Y
47.93% 34.01%
Sales past 3/5Y
- -16.47%
EPS Y/Y TTM
90.06%
Sales Y/Y TTM
452.71%
EPS Q/Q
2168.57%
Sales Q/Q
167.90%
Insider Own
17.53%
Insider Trans
0.30%
Inst Own
20.18%
Inst Trans
-7.44%
ROA
34.58%
ROE
37.22%
ROIC
27.87%
Gross Margin
-
Oper. Margin
-820.78%
Profit Margin
-187.38%
SMA20
-23.71%
SMA50
-34.90%
SMA200
-36.92%
Trades
Shs Outstand
15.44M
Shs Float
12.77M
52W High
5.03 -58.61%
52W Low
2.27 -8.31%
Volatility
9.93% 9.21%
ATR (14)
0.25
RSI (14)
29.68
Beta
2.82
Rel Volume
0.71
Avg Volume
428.91K
Volume
304,367
Perf Week
-19.38%
Perf Month
-28.77%
Perf Quarter
-36.20%
Perf Half Y
-42.54%
Perf YTD
-41.57%
Perf Year
-51.85%
Perf 3Y
-98.07%
Perf 5Y
-99.29%
Perf 10Y
-
Prev Close
2.34
Price
2.08
Change %
-11.11%
Consensus
Strong Buy
Avg. Price Target
$10.22
Implied Upside
+391.3%
Analysts5incl. previous ratings
Rating Distribution3 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 24, 2025Initiated
CChardan Capital Markets
Buy
Dec 16, 2025Initiated
CCantor Fitzgerald
Overweight$4+92.3%
Nov 18, 2024Downgrade
HH.C. Wainwright
Buy → Neutral$12 → $2-3.8%
Mar 01, 2021Initiated
NNorthland Capital
Outperform$10+380.8%
Feb 03, 2020Downgrade
OPY logoOOppenheimer
Outperform → Perform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jung HyunsuSee RemarksJun 01 '26Buy3.707,00025,9201,384,676Jun 02 06:18 PM
Jung HyunsuSee RemarksJun 02 '26Buy3.661,0003,6601,385,676Jun 02 06:18 PM
Knox David R.Chief Financial OfficerDec 31 '25Buy3.5927,950100,340327,950Jan 05 08:00 AM
Strahlman Ellen RDirectorDec 29 '25Buy3.6012,11243,60391,161Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 29 '25Buy3.6111,85642,80034,869Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 26 '25Buy3.863,60113,91179,049Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 26 '25Buy3.863,31112,77723,013Dec 30 04:01 PM
Strahlman Ellen RDirectorDec 18 '25Buy3.1419,70261,83595,150Dec 22 08:15 AM
Strahlman Ellen RDirectorDec 18 '25Buy3.1418,74258,82975,448Dec 22 08:15 AM
Walters Happy DavidDirectorDec 17 '25Buy3.0261,930187,152111,930Dec 19 07:21 PM
GELTZEILER MICHAEL SDirectorDec 17 '25Buy3.0130,00090,21088,015Dec 19 11:00 AM
Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid's native token HYPE. The firm provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. It operates through the following segments: Ophthalmic Technology and Digital Assets. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
CEOMr. Hyunsu Jung